Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Mark Dynamics Indonesia Tbk. (MARK) Price & Performance

UBC Medical Indonesia Tbk.Trade
Mark Dynamics Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Mark Dynamics Indonesia Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume), while Mark Dynamics Indonesia Tbk. trades at Rp1,125 (market cap 4.18T, 26.75M 24h volume). The key difference: Mark Dynamics Indonesia Tbk. is far larger — about 7.2× UBC Medical Indonesia Tbk.'s market cap, and Mark Dynamics Indonesia Tbk. is more actively traded (26.75M versus 3.48M). Which is the better fit depends on your goals.

LABSMARK
Market Cap
576.7B4.18T
Volume
3.48M26.75M
Lot
34.82K267.48K
Turnover
522.79M29.98B
Average Price
150.131,120.77
Value
522.79M29.98B
Indicative Equilibrium Price
1481,125
Indicative Equilibrium Volume
350246

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
MARK
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Mark Dynamics Indonesia Tbk.

PT Mark Dynamics Indonesia Tbk (the Company) was established based on the Deed No. 03 dated April 10, 2002 drawn up before Fibriani Magdalena Hasibuan, SH Notary in Medan. The Company started its commercial operations in September 2003. In 2013 the company decided to invest by purchasing 100% of Honor Tower SDN BHD.

Read more on MARK